X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (145) 145
index medicus (93) 93
oncology (80) 80
multiple myeloma (75) 75
animals (61) 61
cancer (52) 52
mice (45) 45
hematology (44) 44
female (42) 42
multiple myeloma - pathology (42) 42
multiple myeloma - genetics (41) 41
male (39) 39
cell line, tumor (38) 38
microrna (35) 35
multiple myeloma - drug therapy (35) 35
mice, scid (33) 33
apoptosis (31) 31
human necessities (30) 30
hygiene (30) 30
medical or veterinary science (30) 30
antitumor-activity (29) 29
expression (29) 29
micrornas - genetics (29) 29
in-vitro (28) 28
middle aged (27) 27
preparations for medical, dental, or toilet purposes (27) 27
multiple myeloma - metabolism (25) 25
aged (22) 22
cells (22) 22
chemistry (21) 21
metallurgy (21) 21
tumor cells, cultured (21) 21
antineoplastic agents - pharmacology (20) 20
gene expression regulation, neoplastic (20) 20
mirna (20) 20
xenograft model antitumor assays (20) 20
gene expression profiling (19) 19
antineoplastic agents - therapeutic use (18) 18
analysis (17) 17
apoptosis - drug effects (17) 17
biochemistry (17) 17
gene expression (17) 17
growth (17) 17
micrornas (17) 17
multiple myeloma - therapy (17) 17
multiple-myeloma (17) 17
prognosis (17) 17
cell proliferation (16) 16
chemotherapy (16) 16
specific therapeutic activity of chemical compounds ormedicinal preparations (16) 16
adult (15) 15
cell biology (15) 15
immunotherapy (15) 15
medicine, research & experimental (15) 15
survival (15) 15
up-regulation (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
cell proliferation - drug effects (14) 14
article (13) 13
bortezomib (13) 13
care and treatment (13) 13
down-regulation (13) 13
drug synergism (13) 13
immunology (13) 13
research (13) 13
tumors (13) 13
activation (12) 12
beer (12) 12
biology (12) 12
compositions thereof (12) 12
culture media (12) 12
enzymology (12) 12
in-vivo (12) 12
microbiology (12) 12
microorganisms or enzymes (12) 12
mutation or genetic engineering (12) 12
propagating, preserving or maintaining microorganisms (12) 12
research paper (12) 12
review (12) 12
spirits (12) 12
treatment outcome (12) 12
vinegar (12) 12
wine (12) 12
gemcitabine (11) 11
medical research (11) 11
nf-kappa-b (11) 11
ovarian cancer (11) 11
peptides (11) 11
pharmacology & pharmacy (11) 11
proteins (11) 11
therapy (11) 11
brca1 (10) 10
colorectal cancer (10) 10
disease-free survival (10) 10
multiple myeloma - immunology (10) 10
organic chemistry (10) 10
signal transduction - drug effects (10) 10
transfection (10) 10
breast cancer (9) 9
breast-cancer (9) 9
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (377) 377
French (12) 12
Italian (8) 8
German (5) 5
Chinese (1) 1
Korean (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Journal Article
Molecular Therapy - Nucleic Acids, ISSN 2162-2531, 01/2014, Volume 3, Issue 9, pp. e195 - e195
The microRNA(miRNA)-34a is a key regulator of tumor suppression. It controls the expression of a plethora of target proteins involved in cell cycle,... 
delivery | multiple myeloma | cell cycle | miR-34a | DNA damage | nanotechnology | apoptosis | microRNA | cancer | p53 | MicroRNA | Cell cycle | Multiple myeloma | Delivery | Nanotechnology | Apoptosis | Cancer | MULTIPLE-MYELOMA | MEDICINE, RESEARCH & EXPERIMENTAL | PANCREATIC-CANCER | DOWN-REGULATION | CELL-PROLIFERATION | ANTITUMOR-ACTIVITY | FEEDBACK LOOP | COLON-CANCER | IN-VITRO | REGULATING MIR-34A | MICRORNA EXPRESSION | Review
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 05/2018, Volume 11, Issue 1, pp. 63 - 19
The deeper understanding of non-coding RNAs has recently changed the dogma of molecular biology assuming protein-coding genes as unique functional biological... 
Epigenetics | Experimental therapeutics | MALAT1 | lncRNA | Non-coding RNA | Long non-coding RNA | MULTIPLE-MYELOMA | DOWN-REGULATION | CERVICAL-CANCER | CANCER CELL-PROLIFERATION | LUNG-CANCER | LNCRNA MALAT1 | MESSENGER-RNA | INTEGRATIVE ANNOTATION | ONCOLOGY | POOR-PROGNOSIS | HEMATOLOGY | UP-REGULATION | Physiological aspects | Antisense RNA | Care and treatment | Research | Methods | Cancer
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 07/2013, Volume 228, Issue 7, pp. 1506 - 1515
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 09/2018, Volume 32, Issue 9, pp. 1948 - 1957
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 05/2014, Volume 9, Issue 1, pp. 2359 - 2372
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e89659
Background & Aim: The miR-221/222 cluster is upregulated in malignant plasma cells from multiple myeloma (MM) patients harboring the t(4;14) translocation. We... 
MIR-221 | SURVIVAL | RENAL FIBROSIS | GLIOBLASTOMA | PROSTATE CARCINOMA | INHIBITION | MULTIDISCIPLINARY SCIENCES | DOWN-REGULATION | ANTITUMOR-ACTIVITY | MICRORNA EXPRESSION | PROGRESSION | MicroRNAs - therapeutic use | MicroRNAs - antagonists & inhibitors | Humans | Gene Silencing | Male | Antineoplastic Agents - therapeutic use | Mice, SCID | Molecular Targeted Therapy | MicroRNAs - pharmacology | Xenograft Model Antitumor Assays | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Multiple Myeloma - drug therapy | Animals | Cell Line, Tumor | Mice, Inbred NOD | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | MicroRNAs - genetics | Gene Expression Regulation, Neoplastic - drug effects | Multiple Myeloma - genetics | Cyclin-Dependent Kinase Inhibitor p27 - genetics | Immunohistochemistry | RNA | Analysis | Multiple myeloma | Cell proliferation | Severe combined immunodeficiency | Toxicity | Leukemia | Oncology | Infections | Kinases | Anticancer properties | Antitumor agents | Xenografts | Biocompatibility | Phosphorothioate | Translocation | Medical research | Diabetes mellitus | Cyclin-dependent kinases | Immunodeficiency | Organs | Antisense oligonucleotides | Gene expression | Ribonucleic acid--RNA | College campuses | Medicine | Inhibitors | Acids | MicroRNAs | Cyclin-dependent kinase inhibitor p27 | Plasma cells | In vivo methods and tests | Clinical medicine | In vitro methods and tests | Cancer | Tumors | Ribonucleic acid
Journal Article